- videocam Live Webinar with Live Q&A
- calendar_month December 8, 2026 @ 1:00 PM ET/10:00 AM PT
- signal_cellular_alt Intermediate
- card_travel Health
- schedule 90 minutes
New DOJ National Fraud Enforcement Division: Healthcare Impact, High-Tech Resources, Extensive Prosecutorial Authority
Insights From the McDonald Memorandum and DOJ Final Rule; Best Practices for Compliance
Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE webinar will examine the DOJ's final rule formalizing the National Fraud Enforcement Division (Fraud Division) and the memorandum released by Assistant Attorney General Colin McDonald (McDonald Memorandum) setting forth the Fraud Division's enforcement priorities across five areas including a heightened scrutiny of healthcare. The panel will discuss the Fraud Division's infrastructure and extensive prosecutorial authority, high-tech enforcement tools, and the potential impact on healthcare clients. The panel will also offer best practices for mitigating the risk of noncompliance.
Description
The DOJ recently published a final rule formalizing the Fraud Division and a memorandum describing the Fraud Division's enforcement priorities including a heightened focus on healthcare.
The final rule describes the Fraud Division's extensive prosecutorial authority and jurisdiction over a broad range of fraud-related matters including health plan fraud (now assigned exclusively to the Fraud Division rather than the DOJ Criminal Division) and more general healthcare fraud. The rule also indicates that the Fraud Division will now have concurrent jurisdiction with the Criminal Division over controlled substances matters. Importantly, the final rule also grants the Fraud Division authority to prosecute any federal crime discovered during an investigation even if it falls outside the enumerated subject matter enforcement areas.
The McDonald Memorandum provides additional insight as it sets forth the Fraud Division's enforcement priorities across five areas including a heightened scrutiny of healthcare given that national healthcare expenditures are expected to grow from "over $3 trillion a year to over $7 trillion, and estimates are that between 3-10% of that amount is lost to fraud." The memorandum indicates that the division will dedicate increased resources to rooting out fraud including utilizing "cutting-edge" data analysis and technology to target a variety of health-related areas including telemedicine program fraud, Medicare or Medicaid fraud, controlled substance diversion, home health schemes involving illegal kickbacks, and the marketing of unsafe products and services.
Counsel for healthcare stakeholders should understand how this new division and its enforcement priorities may impact their clients and what they should be doing now to mitigate the risk of enforcement action including reviewing compliance programs and self-disclosure frameworks and preparing for possible investigations.
Listen as our authoritative panel examines the establishment of the Fraud Division, reviews its enforcement priorities particularly related to healthcare, and offers best practices for compliance.
Presented By
Mr. Jaworski is an accomplished trial attorney who spent more than 17 years at the U.S. Department of Justice (DOJ), most recently serving as the Acting U.S. Attorney for the Middle District of Tennessee, a district recognized as the country's health care hub. Clients benefit from his insider knowledge of how prosecutors and law enforcement officers think, investigate, and try their cases. Mr. Jaworski defends clients in white-collar criminal matters, health care fraud cases, and False Claims Act matters, including qui tam litigation alleging Stark Law and Anti-Kickback Statute violations and billing and coding issues. He has handled a broad range of white-collar cases, including contract disputes, tax violations, financial fraud, public corruption, international sanctions, money laundering, and computer crimes. Clients also look to Mr. Jaworski to lead sensitive corporate and workplace internal investigations, including those involving allegations of senior executive misconduct, compliance failures, or potential federal regulatory violations. As the Acting U.S. Attorney for the Middle District of Tennessee, Mr. Jaworski directed efforts to combat fraud, waste, and abuse in the health care sector and successfully resolved numerous high-profile health care fraud enforcement cases involving hospitals, academic medical centers, nursing facilities, Medicare Advantage organizations, and other health care providers. He previously held other prominent leadership roles within the DOJ in Nashville, including First Assistant U.S. Attorney and Assistant U.S. Attorney in the White Collar and Economic Crime Unit, and served on the White Collar Fraud Subcommittee of the Attorney General's Advisory Committee.
Mr. O'Connell is Managing Shareholder in the firm’s Washington, D.C., office and a member of the Government Enforcement and Investigations Group. He represents corporate and individual clients in white collar and regulatory defense matters, including claims involving health care fraud, tax, the Foreign Corrupt Practices Act (FCPA), and the False Claims Act (FCA). Mr. O'Connell frequently represents his clients before the Department of Justice, the Securities and Exchange Commission, state attorneys general, and other regulatory agencies. Having directed both criminal and civil Department of Justice (DOJ) investigations, he is uniquely situated to provide compliance counseling, conduct internal investigations, navigate and counter government investigations and – if need be – defend government allegations at every stage of litigation. Mr. O'Connell also regularly advises companies about the effectiveness of their compliance programs and assists companies that are facing investigations by enforcement agencies outside of the U.S. He has represented several large health care clients in responding to investigations of potential violations of the FCA, the Anti-Kickback Statute, and related regulations. Mr. O'Connell's experience includes more than 13 years serving as a trial attorney with the DOJ's Criminal Fraud Section and the Criminal Tax Division, as an Assistant U.S. Attorney with the U.S. Attorneys' Offices for the District of Maryland and the Western District of Texas, and as a Special Assistant U.S. Attorney with the U.S. Attorneys' Offices for the Eastern District of Virginia and the Eastern District of Pennsylvania. He joined the DOJ as a trial attorney through the Attorney General's Honors Program and led investigations and prosecutions into a wide variety of white collar crimes, including health care, tax, bank, wire, mail, and securities fraud; money laundering; public corruption; and the FCPA.
Mr. Porter focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, with an emphasis on matters within the healthcare industry. As a former federal prosecutor with the DOJ, he was a key member of multiple international healthcare fraud takedowns and prosecuted a series of high-profile financial crime cases. Mr. Porter also handled major civil investigations and litigation against companies and individuals under the False Claims Act, resulting in record-breaking settlements and judgments. He now uses that experience to guide clients through federal investigations of all kinds, to litigate cases against and involving the government, and to run effective and right-sized internal investigations for corporations. Many of Mr. Porter’s clients are in the healthcare industry, including health systems, physician groups, and other healthcare companies, along with medical professionals and executives. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Tuesday, December 8, 2026
- schedule
1:00 PM ET/10:00 AM PT
I. Introduction: overview of the current administration's fraud focus
II. New DOJ Fraud Division: insights from the McDonald Memorandum and DOJ final rule
A. Division infrastructure
B. Jurisdiction and sweeping prosecutorial authority
C. Enforcement priorities
D. Healthcare focus
E. Remaining questions
III. Potential impact on healthcare stakeholders
IV. Key takeaways
The panel will review these and other important questions:
- How does the Fraud Division's infrastructure indicate a heightened focus on rooting out fraud?
- What prosecutorial authority does the Fraud Division now have? How does the rule grant the division sweeping authority to prosecute any federal crime discovered during its investigations?
- What impact will the Fraud Division's increased scrutiny of healthcare have on stakeholders? What open questions remain?
- What should counsel and their healthcare clients be doing now to mitigate the risk of enforcement action?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement